First Wave BioPharma Begins Patient Screening for Phase 2b Clinical Trial Evaluating Niclosamide in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis

NEXT STORY
Senti Bio Awarded Funding from National Cancer Institute (NCI) to Support Development of Logic Gated Allogeneic CAR-NK Cell Therapy SENTI-202 to Treat Acute Myeloid Leukemia
PREV STORY
Orphan Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress

author_avatar
NASDAQ Market News

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2

author_avatar
NASDAQ Market News

Molecular Diagnostics Market to register 8.5% CAGR to cross $12.5 billion by 2024: Global Market Insights, Inc.

Molecular Diagnostics Market By Application, By Technology and Regional Outlook (U.S., Canada, Germany, UK, ...

author_avatar
NASDAQ Market News